158 related articles for article (PubMed ID: 12208731)
1. Expression of cIAP1, a target for 11q22 amplification, correlates with resistance of cervical cancers to radiotherapy.
Imoto I; Tsuda H; Hirasawa A; Miura M; Sakamoto M; Hirohashi S; Inazawa J
Cancer Res; 2002 Sep; 62(17):4860-6. PubMed ID: 12208731
[TBL] [Abstract][Full Text] [Related]
2. Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas.
Imoto I; Yang ZQ; Pimkhaokham A; Tsuda H; Shimada Y; Imamura M; Ohki M; Inazawa J
Cancer Res; 2001 Sep; 61(18):6629-34. PubMed ID: 11559525
[TBL] [Abstract][Full Text] [Related]
3. Recurring Amplification at 11q22.1-q22.2 Locus Plays an Important Role in Lymph Node Metastasis and Radioresistance in OSCC.
Bhosale PG; Pandey M; Cristea S; Shah M; Patil A; Beerenwinkel N; Schäffer AA; Mahimkar MB
Sci Rep; 2017 Nov; 7(1):16051. PubMed ID: 29167558
[TBL] [Abstract][Full Text] [Related]
4. BIRC2 amplification in squamous cell carcinomas of the uterine cervix.
Choschzick M; Tabibzada AM; Gieseking F; Woelber L; Jaenicke F; Sauter G; Simon R
Virchows Arch; 2012 Aug; 461(2):123-8. PubMed ID: 22733500
[TBL] [Abstract][Full Text] [Related]
5. Aurora-A affects radiosenstivity in cervical squamous cell carcinoma and predicts poor prognosis.
Ma Y; Yang J; Wang R; Zhang Z; Qi X; Liu C; Ma M
Oncotarget; 2017 May; 8(19):31509-31520. PubMed ID: 28404933
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A
Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237
[TBL] [Abstract][Full Text] [Related]
7. Amplification and up-regulation of MIR30D was associated with disease progression of cervical squamous cell carcinomas.
Zhou Y; Hao Y; Li Y; Li R; Wu R; Wang S; Fang Z
BMC Cancer; 2017 Mar; 17(1):230. PubMed ID: 28356144
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes.
Dai Z; Zhu WG; Morrison CD; Brena RM; Smiraglia DJ; Raval A; Wu YZ; Rush LJ; Ross P; Molina JR; Otterson GA; Plass C
Hum Mol Genet; 2003 Apr; 12(7):791-801. PubMed ID: 12651874
[TBL] [Abstract][Full Text] [Related]
9. Expression of the bric-a-brac tramtrack broad complex protein NAC-1 in cervical carcinomas seems to correlate with poorer prognosis.
Yeasmin S; Nakayama K; Ishibashi M; Katagiri A; Iida K; Purwana IN; Nakayama N; Miyazaki K
Clin Cancer Res; 2008 Mar; 14(6):1686-91. PubMed ID: 18347169
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity on chromosomes 2p, 3p, 18q21.3 and 11p15.5 as a poor prognostic factor in stage II and III (FIGO) cervical cancer treated by radiotherapy.
Kozlowski L; Filipowski T; Rucinska M; Pepinski W; Janica J; Skawronska M; Poznanski J; Wojtukiewicz MZ
Neoplasma; 2006; 53(5):440-3. PubMed ID: 17013540
[TBL] [Abstract][Full Text] [Related]
11. Differential radiation sensitization of human cervical cancer cell lines by the proteasome inhibitor velcade (bortezomib, PS-341).
Kamer S; Ren Q; Dicker AP
Arch Gynecol Obstet; 2009 Jan; 279(1):41-6. PubMed ID: 18461345
[TBL] [Abstract][Full Text] [Related]
12. Biological and clinical significance of NAC1 expression in cervical carcinomas: a comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas.
Yeasmin S; Nakayama K; Rahman MT; Rahman M; Ishikawa M; Katagiri A; Iida K; Nakayama N; Otuski Y; Kobayashi H; Nakayama S; Miyazaki K
Hum Pathol; 2012 Apr; 43(4):506-19. PubMed ID: 21889186
[TBL] [Abstract][Full Text] [Related]
13. Nuclear survivin is associated with cell proliferative advantage in uterine cervical carcinomas during radiation therapy.
Chaopotong P; Kajita S; Hashimura M; Saegusa M
J Clin Pathol; 2012 May; 65(5):424-30. PubMed ID: 22389513
[TBL] [Abstract][Full Text] [Related]
14. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification.
Shuster MI; Han L; Le Beau MM; Davis E; Sawicki M; Lese CM; Park NH; Colicelli J; Gollin SM
Genes Chromosomes Cancer; 2000 Jun; 28(2):153-63. PubMed ID: 10825000
[TBL] [Abstract][Full Text] [Related]
15. Correlation between survivin expression and locoregional control in cervical squamous cell carcinomas treated with radiation therapy.
Suzuki Y; Oka K; Yoshida D; Shirai K; Ohno T; Kato S; Tsujii H; Nakano T
Gynecol Oncol; 2007 Mar; 104(3):642-6. PubMed ID: 17141299
[TBL] [Abstract][Full Text] [Related]
16. The telomere/telomerase binding factor PinX1 regulates paclitaxel sensitivity depending on spindle assembly checkpoint in human cervical squamous cell carcinomas.
Tian XP; Qian D; He LR; Huang H; Mai SJ; Li CP; Huang XX; Cai MY; Liao YJ; Kung HF; Zeng YX; Xie D
Cancer Lett; 2014 Oct; 353(1):104-14. PubMed ID: 25045845
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of Ubiquitin-Specific Protease 53 Enhances the Radiosensitivity of Human Cervical Squamous Cell Carcinoma by Regulating DNA Damage-Binding Protein 2.
Zhou Q; Yao X; Wu C; Chen S; Fan D
Technol Cancer Res Treat; 2020; 19():1533033820929792. PubMed ID: 32508265
[TBL] [Abstract][Full Text] [Related]
18. Constitutive STAT5 activation correlates with better survival in cervical cancer patients treated with radiation therapy.
Chen HH; Chou CY; Wu YH; Hsueh WT; Hsu CH; Guo HR; Lee WY; Su WC
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):658-66. PubMed ID: 21300446
[TBL] [Abstract][Full Text] [Related]
19. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.
Jares P; Fernández PL; Campo E; Nadal A; Bosch F; Aiza G; Nayach I; Traserra J; Cardesa A
Cancer Res; 1994 Sep; 54(17):4813-7. PubMed ID: 8062283
[TBL] [Abstract][Full Text] [Related]
20. Invasion of uterine cervical squamous cell carcinoma cells is facilitated by locoregional interaction with cancer-associated fibroblasts via activating transforming growth factor-beta.
Nagura M; Matsumura N; Baba T; Murakami R; Kharma B; Hamanishi J; Yamaguchi K; Abiko K; Koshiyama M; Mandai M; Murata T; Murphy SK; Konishi I
Gynecol Oncol; 2015 Jan; 136(1):104-11. PubMed ID: 25434636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
